# LuNatal DHA (ascorbic acid,cholecalciferol,.alpha.-tocopherol acetate,dl-,pyridoxine hydrochl) by Skya Health, LLC: new human prescription drug listing

**Launch Signal Score:** 40/100

| Field | Value |
|---|---|
| Product | LuNatal DHA |
| Generic name | ascorbic acid,cholecalciferol,.alpha.-tocopherol acetate,dl-,pyridoxine hydrochloride,levomefolate calcium,folic acid,cyanocobalamin,biotin,calcium carbonate,iron,potassium iodide,magnesium oxide,fish oil |
| NDC | 73086-201 |
| Labeler | Skya Health, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Approval pathway | UNAPPROVED DRUG OTHER |
| Dosage form | CAPSULE, GELATIN COATED |
| Route | ORAL |
| Active ingredients | ASCORBIC ACID 60 mg/1; CHOLECALCIFEROL 1000 [iU]/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 10 [iU]/1; PYRIDOXINE HYDROCHLORIDE 26 mg/1; LEVOMEFOLATE CALCIUM 600 ug/1; FOLIC ACID 400 ug/1; CYANOCOBALAMIN 13 ug/1; BIOTIN 280 ug/1 |
| Marketing start | 2026-09-04 |
| Package configurations | 1 |

## Why this score
- Prescription or biologic product.

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=73086-201). Last refreshed: 2026-11-04T18:12:05.743Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.